The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.
The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.
复制标题
DOI:
10.1371/journal.pgen.1005937
复制
发表时间:
2016-04
期刊:
影响因子:
4.5
通讯作者:
Lydon JP
中科院分区:
文献类型:
--
作者:
Kommagani R;Szwarc MM;Vasquez YM;Peavey MC;Mazur EC;Gibbons WE;Lanz RB;DeMayo FJ;Lydon JP
Progesterone, via the progesterone receptor (PGR), is essential for endometrial stromal cell decidualization, a cellular transformation event in which stromal fibroblasts differentiate into decidual cells. Uterine decidualization supports embryo implantation and placentation as well as subsequent events, which together ensure a successful pregnancy. Accordingly, impaired decidualization results not only in implantation failure or early fetal miscarriage, but also may lead to potential adverse outcomes in all three pregnancy trimesters. Transcriptional reprogramming on a genome-wide scale underlies progesterone dependent decidualization of the human endometrial stromal cell (hESC). However, identification of the functionally essential signals encoded by these global transcriptional changes remains incomplete. Importantly, this knowledge-gap undercuts future efforts to improve diagnosis and treatment of implantation failure based on a dysfunctional endometrium. By integrating genome-wide datasets derived from decidualization of hESCs in culture, we reveal that the promyelocytic leukemia zinc finger (PLZF) transcription factor is rapidly induced by progesterone and that this induction is indispensable for progesterone-dependent decidualization. Chromatin immunoprecipitation followed by next generation sequencing (ChIP-Seq) identified at least ten progesterone response elements within the PLZF gene, indicating that PLZF may act as a direct target of PGR signaling. The spatiotemporal expression profile for PLZF in both the human and mouse endometrium offers further support for stromal PLZF as a mediator of the progesterone decidual signal. To identify functional targets of PLZF, integration of PLZF ChIP-Seq and RNA Pol II RNA-Seq datasets revealed that the early growth response 1 (EGR1) transcription factor is a PLZF target for which its level of expression must be reduced to enable progesterone dependent hESC decidualization. Apart from furnishing essential insights into the molecular mechanisms by which progesterone drives hESC decidualization, our findings provide a new conceptual framework that could lead to new avenues for diagnosis and/or treatment of adverse reproductive outcomes associated with a dysfunctional uterus. Following embryo attachment to the uterine epithelium, the underlying decidualized stroma is critical for further invasion by the conceptus into the maternal compartment. Because endometrial decidualization is required early in the continuum of events that lead to a successful pregnancy, abnormal decidualization can contribute not only to implantation failure or early miscarriage, but may initiate adverse reproductive outcomes that manifest in subsequent pregnancy trimesters. Genome-wide transcriptional changes by progesterone are known to underlie decidualization; however, the pivotal signals that functionally enable progesterone-driven decidualization are not fully known. Using an integrative analysis of genome-scale data along with studies on primary human endometrial stromal cells (hESCs), we reveal that the promyelocytic leukemia zinc finger (PLZF) transcription factor is rapidly induced by progesterone, and its induction is essential for progesterone-dependent hESC decidualization. Although PLZF in turn governs a remarkable array of target genes in the hESC, we demonstrate that PLZF tightly regulates the expression level of the early growth response 1 (EGR1) transcription factor, the perturbation of which compromises progesterone dependent decidualization. Together, our findings provide a new mechanistic perspective on progesterone action in the uterus which may furnish new opportunities for the formulation of more effective fertility solutions in the future.